Gordon E. Crofoot

3.7k citations
41 papers · 2.8k · 3 hit papers · h-index 23

Impact in

    • HIV/AIDS drug development and treatment
    • HIV/AIDS Research and Interventions
    • COVID-19 Clinical Research Studies
  • Virology top 5%
    • HIV Research and Treatment

Papers in

    • HIV/AIDS drug development and treatment 33
    • HIV/AIDS Research and Interventions 3
    • COVID-19 Clinical Research Studies 1
    • Pneumonia and Respiratory Infections 1

Gordon E. Crofoot

40 papers receiving 2.7k citations

Gordon E. Crofoot's Hit Papers

Twice-Yearly Lenacapavir for HIV Prevention in Men and Gender-Diverse Persons 2024 · 133 citations
1330+3+7Years since publication100200300400500

Peers

Gordon E. Crofoot
Comparison fields: 5 of 44
  • Infectious Diseases 1.8k
  • Virology 149
  • Emergency Medicine 197
  • Epidemiology 154
  • Nephrology 32
Replace Marshall W. Fordyce with:
Marshall W. Fordyce United States
Anthony Mills United States
Kirsten White United States
Martin S. Rhee United States
Clare A. Brennan United States
Vadim Valentinovich Pokrovsky Russia
Ellen Koenig United States
Christoph C Carter United States
Damian J. McColl United States
Erin K. Quirk United States
Gordon E. Crofoot relative to Marshall W. Fordyce United States Marshall W. Fordyce's profile →
Citations per field
00.5×2×4×6×8×10×
Marshall W. Fordyce · 1×
Citations per year

Countries citing papers authored by Gordon E. Crofoot

Since Specialization
Citations

This map shows the geographic impact of Gordon E. Crofoot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gordon E. Crofoot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gordon E. Crofoot more than expected).

Fields of papers citing papers by Gordon E. Crofoot

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gordon E. Crofoot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gordon E. Crofoot. The network helps show where Gordon E. Crofoot may publish in the future.

Co-authors

The 25 scholars most cited alongside Gordon E. Crofoot, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Gordon E. Crofoot Line = papers co-authored together Gordon E. Crofoot links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 41 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Tenofovir alafenamide versus tenofovir disoproxil fumarate, coformulated with elvitegravir, cobicistat, and emtricitabine, for initial treatment of HIV-1 infection: two randomised, double-blind, phase 3, non-inferiority trials
Hit paper breakdown →
2015515
2 2020329
3
Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2): week 48 results from two multicentre, double-blind, randomised, non-inferiority, phase 3 trials
Hit paper breakdown →
2018313
4 2015174
5 2018141
6 2015135
7
Twice-Yearly Lenacapavir for HIV Prevention in Men and Gender-Diverse Persons
Hit paper breakdown →
2024133
8 1992121
9 202289
10 201782
11 201782
12 202182
13 202171
14 201769
15 201457
16 202354
17 201653
18 201743
19 202436
20 201934

About Gordon E. Crofoot

Gordon E. Crofoot is a scholar working on Infectious Diseases, Epidemiology, Nuclear Energy and Engineering, Waste Management and Disposal and Organic Chemistry, having authored 41 papers that have together received 2.8k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (33 papers), HIV/AIDS Research and Interventions (3 papers), COVID-19 Clinical Research Studies (1 paper) and Pneumonia and Respiratory Infections (1 paper). The work is most often cited by research in Infectious Diseases (1.8k citations), Virology (149 citations), Emergency Medicine (197 citations), Epidemiology (154 citations) and Nephrology (32 citations). Gordon E. Crofoot has collaborated with scholars based in United States, United Kingdom and Spain. Frequent co-authors include Andrew Cheng, Joseph M. Custodio, Paul M. Benson, Moti N. Ramgopal, Edwin DeJesus, Anthony Mills, Hal Martin, Peter Jerome Ruane, Scott H. McCallister and Joseph Gathe. Their work appears in journals such as The Lancet HIV, The Lancet, Open Forum Infectious Diseases, JAIDS Journal of Acquired Immune Deficiency Syndromes and The Journal of Infectious Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact